Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
Corticosteroids mitigate 28-day all-cause mortality in coronavirus disease-2019 (COVID-19) patients requiring oxygen or mechanical ventilation (meta-analysis summary odds ratio (OR), 0.66; 95%-confidence interval (95%IC), [0.53-0.82]; P
Source: Journal of Infection - Category: Infectious Diseases Authors: Jean-Philippe Kevorkian, Amanda Lopes, Damien S ène, Jean-Pierre Riveline, Claire Vandiedonck, Florine Féron, Kladoum Nassarmadji, Stéphane Mouly, Franck Mauvais-Jarvis, Jean-François Gautier, Bruno Mégarbane Tags: Letters to the Editor Source Type: research
More News: Aspirin | Colchicine | Colcrys | Coronavirus | Corticosteroid Therapy | COVID-19 | Furosemide | Infectious Diseases | Study